Home

Breaking News in IBD:

Advancing Confidence in Optimizing Anti-TNF Treatment Across the Care Continuum CME

Sheraton Phoenix Downtown

Monday, October 27, 2025 | 7:30 PM - 8:45 PM TZ

Supported by an independent educational grant from Celltrion USA, Inc.

overview

This live event will spotlight the latest evidence on timing, dosing, and safety of anti-TNF therapies. Participants will learn practical, evidence-based recommendations to optimize anti-TNF treatment, personalize switches between agents, and apply novel formulations in moderate to severe Crohn’s disease and ulcerative colitis. By the end of this activity, attendees will feel more confident identifying non-responders, making timely therapeutic adjustments, and integrating anti-TNF strategies into comprehensive patient care.

This event is neither sponsored by nor endorsed by ACG.

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

MODERATOR

Bruce Sands, MD, MS

Dr Burrill B. Crohn Professor of Medicine

Icahn School of Medicine at Mount Sinai

New York, New York

FACULTY

Aline Charabaty, MD, AGAF, FACG

Associate Professor of Medicine

Johns Hopkins School of Medicine

Medical Director of the Division of Gastroenterology and Hepatology

Director of the IBD Center

Johns Hopkins Sibley Memorial Hospital

Washington, DC

FACULTY

Millie Long, MD, MPH

Vice Chief of Education

Director of the Fellowship Program

Division of Gastroenterology and Hepatology

UNC School of Medicine

Chapel Hill, North Carollina

AGENDA

7:00 PM TZ

Registration and Dinner

7:30 PM TZ

Presentation

Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.

*Video encouraged*

LOCATION

Sheraton Phoenix Downtown

340 N 3rd Street, Phoenix, Arizona, 85004

Room: Phoenix Ballroom E (Level 3)

TARGET AUDIENCE

This educational activity is intended for an audience of gastroenterologists, gastroenterology nurse practitioners (NPs) and physician assistants (PAs), primary care physicians, primary care NPs and PAs, and other healthcare practitioners managing inflammatory bowel disease (IBD) in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to integrate and adjust anti-tumor necrosis factor (TNF) treatment into management plans for patients with moderate to severe IBD and apply novel anti-TNF formulations into patient care.

LEARNING OBJECTIVES

[bold]Upon completion of this activity, participants will:[/bold] [para]Have increased knowledge regarding the[/para][list][item] Evidence-based recommendations to optimize anti-TNF treatment [item]Safety and efficacy data of anti-TNF agents [/list] [para]Have greater competence related to[/para] [list][item]Switching within anti-TNF therapies to personalize management [/list] [para]Demonstrate greater confidence in their ability to[/para] [list][item]Determine when a non-responder should be switched to another anti-TNF treatment [/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[title]For Physicians[/title] [text]Medscape, LLC designates this live activity for a maximum of 1.25 [bold][italic]AMA PRA Category 1 Credit(s)[/italic][super]TM[/super][/bold]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.[/text]